HTA134 Implications of Indication Expansions on Pricing and Reimbursement and How This Differs Between EU4 and UK Markets
Abstract
Authors
M Baig G Nicol R Vadehra P Craddy
M Baig G Nicol R Vadehra P Craddy
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now